Literature DB >> 30988593

Four Limb Ischemia: A Severe Case of Heparin Induced Thrombocytopenia.

Kartik Anand1, Ibrahim Ibrahim2.   

Abstract

Entities:  

Year:  2019        PMID： 30988593      PMCID： PMC6439086          DOI： 10.1007/s12288-019-01083-z

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  6 in total

1.  Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings.

Authors:  G K Lo; D Juhl; T E Warkentin; C S Sigouin; P Eichler; A Greinacher
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

Review 2.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Lori-Ann Linkins; Antonio L Dans; Lisa K Moores; Robert Bona; Bruce L Davidson; Sam Schulman; Mark Crowther
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  HITs and misses in 100 years of heparin.

Authors:  Lawrence Rice
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  Five hematologic tests and treatments to question.

Authors:  Lisa K Hicks; Harriet Bering; Kenneth R Carson; Adam E Haynes; Judith Kleinerman; Vishal Kukreti; Alice Ma; Brigitta U Mueller; Sarah H O'Brien; Julie A Panepinto; Marcelo C Pasquini; Anita Rajasekhar; Ravi Sarode; William A Wood
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

Review 5.  Heparin-induced thrombocytopenia.

Authors:  Gowthami M Arepally
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

6.  Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program.

Authors:  Kelly E McGowan; Joy Makari; Artemis Diamantouros; Claudia Bucci; Peter Rempel; Rita Selby; William Geerts
Journal:  Blood       Date:  2016-01-27       Impact factor: 22.113
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.